常用资源电子图书期刊论文学位会议外文资源特色专题内部出版物 
Wiley电子期刊(3)SpringerLink电子期刊(93)NATURE电子期刊(1)Elsevier电子期刊(131)
在“Elsevier电子期刊”中,命中:131条,耗时:小于0.01 秒

在所有数据库中总计命中:228

3.Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial
6.Assessment of chemotherapy strategy using bevacizumab for non-squamous non-small cell lung cancer in a real-world setting: A multi-institutional observational study
作者:Masayoshi Higashiguchia ; higashiguchim@imed3.med.osaka-u.ac.jp" class="auth_mail" title="E-mail the corresponding author ; Takashi Kijimaa ; tkijima@imed3.med.osaka-u.ac.jp" class="auth_mail" title="E-mail the corresponding author ; Osamu Morimuraa ; morimura@imed3.med.osaka-u.ac.jp" class="auth_mail" title="E-mail the corresponding author ; Akio Osaa ; akio_osa_20080622@yahoo.co.jp" class="auth_mail" title="E-mail the corresponding author ; Hidekazu Suzukib ; suzukih@ra.opho.jp" class="auth_mail" title="E-mail the corresponding author ; Takako Inouec ; okuyama_trial@yahoo.co.jp" class="auth_mail" title="E-mail the corresponding author ; Hiroyuki Kagawad ; hkagawa@toneyama.go.jp" class="auth_mail" title="E-mail the corresponding author ; Kiyonobu Uenoe ; kueno@gh.opho.jp" class="auth_mail" title="E-mail the corresponding author ; Tomonori Hirashimab ; hirashimat@ra.opho.jp" class="auth_mail" title="E-mail the corresponding author ; Toru Kumagaic ; kumagai-to@mc.pref.osaka.jp" class="auth_mail" title="E-mail the corresponding author ; Fumio Imamurac ; imamura-fu@mc.pref.osaka.jp" class="auth_mail" title="E-mail the corresponding author ; Masahide Morid ; mmori@toneyama.go.jp" class="auth_mail" title="E-mail the corresponding author ; Yoshiro Tanioe ; tanioy@gh.opho.jp" class="auth_mail" title="E-mail the corresponding author ; Ichiro Kawaseb ; 1 ; kawase@jinsen.jp" class="auth_mail" title="E-mail the corresponding author
刊名:Cancer Treatment Communications
出版年:2016
7.Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial
1
2
3
4
5
6
7
8
9
按检索点细分(131)
题名(65)
关键词(20)
文摘(80)
按出版年细分(131)
2027年及以后(8)
2017年(5)
2016年(6)
2015年(4)
2013年(16)
2012年(17)
2011年(13)
2010年(10)
2009年(21)
2008年(14)
2007年(5)
2006年(5)
2005年(6)
2004年(1)

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700